Immunological off-target effects of imatinib

Allan Sauvat, Fabiola Ciccosanti, Francesca Colavita, Martina Di Rienzo, Concetta Castilletti, Maria Rosaria Capobianchi, Oliver Kepp, Laurence Zitvogel, Gian María Fimia, Mauro Piacentini, Guido Guido Kroemer

Article2019

Immunological Effects of Epigenetic Modifiers

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

DOI: 10.1038/nrclinonc.2016.41
Year: 2016
Published: —
Language: en

Article Details

Volume: 13
Issue: 7
Link Of The Paper: https://doi.org/10.1038/nrclinonc.2016.41

Timeline

Created:June 19, 2026

Lucillia Bezu, Alejandra Wu Chuang, Peng Liu, Guido Guido Kroemer, Oliver Kepp

Letter2011

Anticancer effects of imatinib via immunostimulation

Laurence Zitvogel, Guido Guido Kroemer

Article2007

Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study

Simone Boehrer, Lionel Adès, Thorsten Braun, Lorenzo Galluzzi, J. Grosjean, Claire Fabre, Geneviève Roux, Claude Gardin, Antoine Martin, Stéphane de Botton, Pierre Fenaux, Guido Guido Kroemer

Article2007

P039 The EGFR-inhibitor erlotinib exhibits various off-target effects in MDS and AML

Simone Boehrer, L. Adàs, Theodore P. Braun, Lorenzo Galluzzi, Joël Grosjean, Claire Fabre, Stéphane de Botton, Claude Gardin, Pierre Fenaux, Guido Guido Kroemer